Investor directory
Droia Ventures
Droia Ventures is dedicated to making an impact in life sciences by investing exclusively in therapeutics that address significant unmet medical needs.
The facts
- Typical cheque
- €1M – €30M
- Headquarters
- Zaventem, Belgium
- Founded
- 2011
Portfolio
Vico TherapeuticsArcus Biosciences (NYS: RCUS)Frontier MedicinesPACT PharmaAura Biosciences (NAS: AURA)Hummingbird BioscienceProtego BiopharmaQurAlisUnnatural ProductsVolastraVaderis TherapeuticsJudo BioHillstar BioMuna TherapeuticsOctimet OncologyVicinitas TherapeuticsHyku BiosciencesMahzi TherapeuticsSummation BioAnanke TherapeuticsMontis BiosciencesConvert PharmaceuticalsAccent TherapeuticsActio Biosciences
and 6 more
Does Droia Ventures fit your round?
Oka scores this fund against your actual raise — stage, sector, cheque size and traction — and shows you who can introduce you.
Check your matchAre you Droia Ventures? Tell us what to correct and we will update it — or ask us to remove the entry.